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Abstract
Background: Data on the performance of interferon-gamma release assays (IGRAs), QuantiFERON TB Gold In-tube (QFNGIT)
and T-Spot.TB, in diagnosing tuberculosis (TB) are limited in Southeast Asia. This study aims to compare the performances of
the two IGRAs and TST in Thai children with recent TB exposure.
Methods: This multicenter, prospective study enrolled children with recent exposure to active TB adults. Children were
investigated for active TB. TST was performed and blood collected for T-Spot.TB and QFNGIT.
Results: 158 children were enrolled (87% TB-exposed and 13% active TB, mean age 7.2 years). Only 3 children had HIV
infection. 66.7% had TST$10 mm, while 38.6% had TST$15 mm. 32.5% had positive QFNGIT; 29.9% had positive T-Spot.TB.
QFNGIT and T-Spot.TB positivity was higher among children with active TB compared with TB-exposed children. No
indeterminate IGRA results were detected. No statistically significant differences between the performances of the IGRAs
and TST at the two cut-offs with increasing TB exposure were detected. Concordance for positive IGRAs and TST ranged
from 42–46% for TST$10 mm and 62–67% for TST$15 mm. On multivariable analyses, exposure to household primary/
secondary caregiver with TB was associated with positive QFNGIT. Higher TB contact score and active TB were associated
with positive T-Spot.TB.
Conclusions: Both QFNGIT and T-Spot.TB performed well in our Thai pediatric study population. No differences in the
performances between tests with increasing TB exposure were found. Due to accessibility and low cost, using TST may more
ideal than IGRAs in diagnosing latent and active TB in healthy children in Thailand and other similar settings.
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Background
Tuberculosis (TB) is a major cause of childhood morbidity and
mortality globally, [1] with children who have contact with an
adult with active pulmonary TB experiencing an elevated risk of
infection. [2] For example, children under the age of one year
have a 50–60% risk of progression to active TB during the first
year of infection, [3] with the risk increased with HIV co-infection.
[4] In 2012 Thailand ranked among 22 high TB burden countries,
with an estimated 80,000 people developing TB annually. [5]
Thirteen percent of TB cases in Thailand are HIV-associated, and
approximately 2,300 TB cases occur in children each year. Among
children exposed to adults with active TB in a Thai study, 7%
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developed active TB while 65% had latent TB; 14% of the
children were HIV-infected [6].
The diagnosis of TB in children is often challenging. [2,7] In
most countries with endemic TB, tuberculin skin test (TST) is used
to diagnose latent TB. However, TST has low sensitivity and
specificity, resulting in imperfect estimation of TB infection risk.
[8–10] Children previously vaccinated with Bacille Calmette-
Gue´rin (BCG) or infected with nontuberculous mycobacteria
frequently have false positive TST reactions. In addition, children
who are malnourished or have HIV or other immunocompro-
mised disease often have false negative TST reactions. [3,11] Data
on the diagnosis of latent and active TB in children using
interferon-gamma release assays (IGRAs), which are based on M.
tuberculosis-specific antigens, are accruing. [8–11] Potential
benefits of IGRAs compared to TST include higher specificity
and increased compliance (unlike TST, IGRAs do not require a
follow-up visit for the test reading). [12] Because IGRAs use more
specific Mycobacterium antigens (ESAT-6, CFP-10, and TB7.7)
encoded by genes in the region of 1 (RD1) of the M. tuberculosis
genome, they are not affected by cross-reactivity with BCG
vaccine strains of M. bovis, [11,13] which provides another
advantage of IGRAs over TST in countries with high BCG
vaccination coverage.
A 2007 meta-analysis showed that the interferon-gamma release
assays, QuantiFERON-TB Gold In-tube (QFNGIT) (a whole
blood assay, Cellestis Limited, Carnegie, Victoria, Australia) and
T-Spot.TB (a T-cell-based assay, Oxford Immunotec, Oxford,
UK), had higher sensitivity than TST (66% and 62%, respectively,
vs. 55%) in detecting latent TB in children. [14] A more recent
meta-analysis [8] of studies among children in low, moderate, and
high income countries observed slightly higher sensitivity and
specificity of IGRAs compared with TST in active TB (pooled
sensitivity of 80% for TST vs. 83–84% for the IGRAs; pooled
specificity of 85% for TST vs. 91–94% for the IGRAs), although
the confidence intervals for both sensitivity and specificity
overlapped. A trend towards lower sensitivity for all three tests
was noted in study samples with high BCG vaccination coverage
in the meta-analysis. Another meta-analysis found that in low-
income countries, IGRAs were not superior to TST. [10] Only
one study, conducted in Papua New Guinea, has been performed
assessing the utility of QFNGIT in latent and active TB diagnosis
in children in Southeast Asia;[15] however, no studies involving a
three-way comparison of the two IGRAs and TST have been
previously completed in Southeast Asia [10].
Using baseline data from our prospective, multi-site cohort
study in Bangkok, Thailand, we compared the performances of the
IGRAs (T-Spot.TB, QuantiFERON-TB Gold In-tube) and TST
at two different cut-off thresholds (10 mm and 15 mm) in Thai
children who had recent exposure to an adult index case with TB
by determining what test correlates better with increasing TB
exposure. We also assessed concordance and discordance between
these tests. In addition, we evaluated factors such as age,
nutritional and immune status, type and duration of contact with
index TB case, and TB infection status on the children’s response
to the IGRAs and TST at the baseline visit. Both 10 mm and
15 mm thresholds were examined in this study (1) to add relevance
to the Thai clinical setting since Thai guidelines recommend
treatment for latent TB in children aged 5–16 years with TST$
15 mm [16], and (2) to add relevance of the study findings to
international settings in which different TST cut-offs are used.
Materials and Methods
This prospective cohort study was conducted between Septem-
ber 2009 and December 2011 at three sites in Bangkok, Thailand:
Queen Sirikit National Institute of Child Health, HIV Netherlands
Australia Thailand (HIV-NAT) Clinic/Chulalongkorn Hospital,
and Siriraj Hospital.
Study Population
Children between the ages of 2 months and 16 years with recent
exposure (defined as having lived with and/or having had close
contact with) to adults with active pulmonary TB (confirmed by
positive AFB stain, PCR for TB, or TB culture), with or without
extrapulmonary TB manifestations, during the past year were
referred to the three study sites for eligibility screening. Interested
subjects were then screened for eligibility, and all parents or
caregivers of the eligible children were asked to provide written
informed consent after presentation and explanation of the study
and consent form. Child assent was obtained from children $7
years of age. Children were excluded if they and/or their
caregivers refused study participation, if they were receiving
anti-TB medications for TB disease (including isoniazid [INH] for
latent TB), or if they had recently been diagnosed with active TB.
Study Procedures
At the baseline visit, the children were evaluated for active TB
with the following components at baseline visit: (1) standardized
patient history (contact and medical history, symptom-based
questionnaire), (2) BCG vaccination history, TB exposure and
TST history, (3) standardized physical examination, (4) chest x-
ray, (4) abdominal ultrasound for subjects with abdominal
symptoms and signs, (5) for those with active symptoms or
abnormal chest x-ray: at least 3 sputum or early morning gastric
aspirate specimens (if child was unable to provide sputum
specimens) for acid fast bacilli (AFB) smear and culture, (6) other
tissue specimens for AFB smear and culture as clinically indicated.
In this study, for HIV status, in accordance with Thai HIV
treatment guidelines that recommend HIV antibody testing for
every pregnant woman during antenatal care, children who were
otherwise healthy, had no history of material positive HIV
serostatus, and had no HIV-related signs and symptoms (such as
hepatosplenomegaly, recurrent bacterial and viral infections,
opportunistic infections) were presumed to have negative HIV
status. The other enrolled children received HIV antibody or viral
load PCR testing.
At the baseline visit, the children had a TST (0.1 ml solution or
10 international units of tuberculin purified protein derivative)
implanted on the forearm followed by result reading by trained
health care personnel in 48–72 hours, in accordance with Thai
national guidelines. The size of TST induration was determined
by measuring the maximum width (or transverse diameter) of an
indurated lesion.
The children had whole blood and peripheral blood mononu-
clear cells collection for the interferon-gamma release assays (T-
Spot.TB and QFNGIT). The blood samples were sent on the same
day of collection to the laboratory of the Department of Allergy
and Immunology, Faculty of Medicine, Chulalongkorn University
for testing according to the manufacturers’ instructions using
positive and negative controls. [17,18] Results for T-Spot.TB were
reported as positive, negative, or indeterminate, [18] while results
for QFNGIT were reported as positive, negative, or indeterminate
according to the manufacturers’ guidelines. [17] Positive cutoff
values for the tests were defined using the manufacturers’ standard
guidelines. Study investigators, site coordinators, and clinicians
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were blinded to the results of the IGRAs until the study had
completed enrollment and 9-month follow-up.
TB Contact Score
A TB contact score was computed using an algorithm modified
from a previous study [3] (Table 1). The TB contact score was
weighted based on the relationship of the TB index case to the
child, type and duration of exposure to index case, and the
infectivity of the index case based on sputum AFB positivity, and
could range from 6 to 19. A TB contact score for each child was
calculated. A mean TB contact score was computed for the overall
cohort and for TB-exposed and active TB cases.
TB Case Definitions
The children were classified into the following categories
independent of results of TST and IGRAs: active TB (definite,
probable, or possible TB) and TB-exposed. Case definitions for
these categories were pre-determined by the investigators prior to
study enrollment. A definite TB case required culture evidence of
Mycobacterium tuberculosis in at least one clinical specimen or
AFB smear positive in at least 2 clinical specimens. A child was
classified as having probable TB if he/she had any of the
following: (1) caseating granuloma on tissue biopsy, (2) spinal
gibbus, or (3) AFB smear positive in 1 clinical specimen plus at
least 1 of the following: (a) chest x-ray findings suggestive of active
TB, (b) cervical lymphadenopathy with sinus, (c) abdominal ascites
or mass with associated lymphadenopathy on radiographic
imaging, (d) clinical symptoms of meningitis with CSF findings
consistent with TB meningitis or neuroradiographic finding of
basal meningeal enhancement or tuberculoma, and (e) erythema
nodosum or phylectenular conjunctivitis with chest x-ray evidence
of primary TB. Children were classified as having possible TB if
the above criteria for definite and probable TB were not fulfilled
and active TB could not be excluded. A child was categorized as
being TB-exposed if he/she met the following criteria: (1)
asymptomatic, (2) had close contact with an active pulmonary
TB (with or without extrapulmonary involvement) adult case
during the past year, and (3) no active TB disease (definite,
probable, possible TB) confirmed.
TB Treatment Course
Children in the study were treated according to Thai national
TB program guidelines. Children who met the following criteria
were started on INH chemoprophylaxis for 9 months: children
aged ,5 years and HIV-infected children with exposure to active
pulmonary TB irrespective of TST result; and children aged 5–16
years with TST$15 mm or recent converter were started on INH
chemoprophylaxis for 9 months. For children aged 5–16 years
with TST between 10 to 15 mm, INH could be considered based
on the judgment of the healthcare provider. [16] If the index adult
case was known to have INH drug resistance, then the child
received rifampicin for 4 months. If the adult index case was
known to have multi-drug resistant TB, the choice of latent TB
medication was based on consultation with the study’s principal
Table 1. Mycobacterium TB contact score.
Variable Weight assigned
TB index case relationship to child
Primary caregiver in household with TB 4
Secondary caregiver in household with TB 3
Relative/other contact in household with TB 2
Non-household TB contact 1
Type of exposure to TB index case
Sleeps in same room 3
Lives and sleeps in same house 2
Lives and sleeps in different house 1












Index TB case history
Sputum AFB negative 2
Sputum AFB positive 4
Total contact score (maximum=19)
doi:10.1371/journal.pone.0105003.t001
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investigators. Subjects who met the study definitions of definite,
probable, or possible TB were treated according to the Thai
national TB program guidelines with a standard four-drug
regimen consisting of INH, rifampicin, ethambutol, and pyrazin-
amide for at least 6 months.
Statistical Analysis
Data were analyzed using SAS version 9.3 (SAS Institute Inc.,
Cary, NC, USA). The proportion of children with positive IGRA
and TST results at the baseline month 0 study visit was compared
using Chi-square test and Fisher’s exact test. We calculated the
Spearman correlation coefficient between positivity of each test
(QFNGIT, TSpot.TB, and TST at 10 mm and 15 mm cutoffs)
and graded TB exposure based on the TB contact score (divided
into 4 categories based on the mean TB contact score) for the total
sample (TB-exposed and active TB) and for TB-exposed only.
Next, we computed the odds ratio (OR) and 95% confidence
interval (CI) of test positivity for each test for each TB exposure
gradient category, with the lowest TB contact score of 8–10 as the
reference group. We then plotted regression lines of the natural
logs of the ORs for each test for each TB exposure gradient
relative to the TB contact score of 8–10. We pre-determined that a
test with a steeper regression slope (i.e., larger change in the
natural log of OR of test positivity with increasing TB exposure)
would have superior performance in detecting infection with TB.
[8] Concordance and discordance between TST at the two cut-off
values and IGRAs for the overall cohort, TB-exposed cases, and
active TB cases was assessed using the kappa statistic. Bivariable
logistic regression was performed to determine whether socio-
demographic variables, study site, TB index case exposure type
and duration, TB contact score, HIV status, nutritional status
(WHO weight-for-age Z-score), and TB infection status were
associated with the following at the baseline visit: (1) having a
positive QFNGIT result, (2) having a positive T-Spot.TB result, (3)
having both a positive QFNGIT and a positive T-Spot.TB result,
(4) having a TST$10 mm, and (5) having a TST$15 mm.
Variables with p-values,0.05 were then selected for the multi-
variable logistic regression models using a forward selection
process. All analyses were two-sided with alpha= 0.05.
The institutional review boards at Chulalongkorn University,
Queen Sirikit National Institute of Child Health, Siriraj Hospital,
Columbia University, and New York Blood Center approved the
study.
Results
A total of 158 children were enrolled in the study, with 137
(87%) meeting the study’s case definition for TB-exposed and 21
(13%) meeting the definition for active TB (2 definite, 6 possible,
and 13 probable TB). An overall summary of the baseline
characteristics of the cohort and a comparison by TB case
classification (TB-exposed vs. active TB) is presented in Table 2.
Overall mean age of the children was 7.2 years (SD 4.2), with
those with active TB being younger than TB-exposed children.
Only 3 (1.9%) were HIV-positive; 11 (7.1%) were HIV-negative;
and 142 (91.0%) were not offered HIV testing due to the lack of
history of parental HIV infection and clinical symptoms consistent
with HIV. Most children, 96.8%, reported BCG vaccination at
birth, with 76.4% of the children had a BCG scar present on
physical exam. Only 1 child had received systemic steroids in the 4
weeks prior to study enrollment. Compared with TB-exposed
cases, children with active TB were more likely to have been
exposed to a secondary caregiver in the household with TB (42.9%
vs. 17.9%) and less likely have been exposed to a primary caregiver
or relative or other contact in the household with TB (28.6% vs.
37.3% and 9.5% vs. 37.3%, respectively, p = 0.004). However,
there were no significant differences in type of exposure and
duration of contact between the adult TB index case and child by
TB infection status. The mean TB contact score was 12.6 (SD 2.0)
for the overall cohort, with no difference detected between active
TB and TB-exposed cases.
Two-thirds of the overall cohort had a TST$10 mm induration
at the baseline visit, while 38.6% had a TST$15 mm induration;
no statistically significant difference was noted by TB infection
status. Overall, 32.5% of the children had a positive QFNGIT
result, while 29.9% had a positive T-Spot.TB result. QFNGIT
positivity was higher among children with active TB compared
with TB-exposed children (52.4% vs. 29.4%, p= 0.04). Similarly,
T-Spot.TB positivity was higher among children with active TB
than TB-exposed children (52.4% vs. 26.5%, p= 0.02). No
indeterminate QFNGIT results and no equivocal/borderline T-
Spot.TB results were detected in the cohort.
Table 3 shows the correlation coefficient of the various tests for
M. tuberculosis with graded TB contact exposure based on the TB
contact score for the total sample (TB-exposed and active TB) and
for TB-exposed only. For the total sample, the correlation
coefficient between TST$10 mm and TB contact exposure was
0.27; TST$15 mm 0.24; QFTGIT 0.31; and T-Spot.TB 0.28.
For TB-exposed only, the correlation coefficient between TST$
10 mm and TB contact exposure was 0.22; TST$15 mm 0.16;
QFTGIT 0.25; and T-Spot.TB 0.21.
In Table 4, the ORs and 95% CIs for positivity of each test for
M. tuberculosis for each exposure gradient category were
compared, with TB contact score of 8–10 as the reference group,
for the total sample and for TB-exposed children only. There were
no statistical significant differences between the tests due to
overlapping CIs for both the total sample and for TB-exposed
only. In addition, the 95% CIs for all the tests were found to be
wide. Figure 1, which depicts the regression lines of the beta
estimates for each test for each TB exposure gradient category
relative to the lowest exposure group, shows that for each test, the
odds of test positivity (slope) increases as the TB exposure
increases. Figure 1 reflects the finding that there were no
significant differences between the performances of the tests with
increase in TB exposure.
Table 5 shows the concordance and discordance between the
IGRAs and TST results at the two TST cut-off thresholds for the
overall cohort and for TB-exposed and active TB cases at the
baseline month 0 visit. For the overall cohort, concordance for
positive IGRAs and positive TST ranged from 41.6–45.5% for the
TST threshold of 10 mm and from 62.1–67.2% for the threshold
of 15 mm. Concordance for negative IGRAs and negative TST
ranged from 92.2–94.1% for the TST cut-off of 10 mm and was
89.4% for the TST threshold of 15 mm. Agreement based on the
kappa statistic between IGRAs and TST at both cut-off values was
higher among children with active TB compared with TB-exposed
children. Agreement based on the kappa statistic was also higher
with TST cut-off of $15 mm compared with $10 mm for the
overall cohort and for both TB-exposed and active TB cases. Of
the 87 TB-exposed children who had a TST$10 mm, 41.4% had
a positive QFNGIT result while 36.8% had a positive T-Spot.TB
result. Among the 47 TB-exposed children who had a TST$
15 mm, QFNGIT positivity increased to 61.7% while T-Spot.TB
positivity increased to 57.5%. Of the 14 children with active TB
who had a TST$10 mm, 71.4% had a positive QFNGIT result,
with the same proportion having a positive T.Spot-TB result.
Among the 11 children with active TB who had a TST$15 mm,
QFNGIT positivity increased to 90.9% while T-Spot.TB positivity
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Baseline Characteristic, N (%)
Age, mean (SD) (years) 7.2 (4.2) 7.6 (4.3) 4.7 (1.7) ,0.001
Gender 0.59
Male 81 (51.6) 69 (50.7) 12 (57.1)
Female 76 (48.4) 67 (49.3) 9 (42.9)
HIV serostatus 0.75{
Positive 3 (1.9) 3 (2.2) 0 (0.0)
Negative 11 (7.1) 9 (6.6) 2(10.0)
Unknown* 142 (91.0) 124 (91.2) 18 (90.0)
History of prior latent or active TB 5 (3.2) 4 (2.9) 1 (4.8) 0.52{
History of BCG vaccination NA
Yes 153 (96.8) 132 (96.4) 21 (100.0)
No 1 (0.6) 1 (0.7) 0 (0.0)
Unknown 4 (2.5) 4 (2.9) 0 (0.0)
BCG scar on physical exam 113 (76.4) 95 (73.6) 18 (94.7) 0.05{
Received any steroids during the last 4 weeks NA
Yes 1 (0.6) 0 (0.0) 1 (4.8)
No 157 (99.4) 137 (100.0) 20 (95.2)
Type and Duration of Exposure
to TB Index Case
TB index case relationship to child 0.004{
Primary caregiver in household with TB 56 (36.1) 50 (37.3) 6 (28.6)
Secondary caregiver in household with TB 33 (21.3) 24 (17.9) 9 (42.9)
Relative/other contact in household with TB 52 (33.6) 50 (37.3) 2 (9.5)
Non-household TB contact 14 (9.0) 10 (7.5) 4 (19.1)
Type of exposure to TB index case 0.73
Sleeps in same room 72 (46.5) 63 (47.0) 9 (42.9)
Lives and sleeps in same house 62 (40.0) 54 (40.3) 8 (38.1)
Lives and sleeps in different house 21 (13.6) 17 (12.7) 4 (19.1)
Duration of average contact
per day with TB index case (hours)
0.82
0–3 2 (1.3) 2 (1.5) 0 (0.0)
4–7 41 (26.8) 34 (25.8) 7 (33.3)
8–11 26 (17.0) 24 (18.2) 2 (9.5)
12+ 84 (54.9) 72 (54.6) 12 (57.1)
Duration of contact with index
case in last 12 months (months)
7.0 (3.9) 6.9 (4.0) 7.7 (3.7) 0.38
Index TB case history
Sputum AFB negative 7 (4.5) 7 (5.2) 0 (0.0) 0.60{
Sputum AFB positive 145 (92.4) 125 (91.9) 20 (95.2) 1.00{
Mycobacterium TB culture positive 7 (4.5) 5 (3.7 2 (9.5) 0.24{
TB contact score 0.27
8–12 61 (41.2) 55 (43.0) 6 (30.0)
13+ 87 (58.8) 73 (57.0) 14 (70.0)
Child’s Clinical Symptoms, Diagnostics, and Treatment Course
Mean weight for age Z-score (SD)









Clinical symptoms and signs NA
Cough 30 (19.0) 25 (18.3) 5 (23.8)
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increased to 81.8%. Concordance for positive QFNGIT and T-
Spot.TB was 85.1% for the overall cohort, 83.3% for TB-exposed
cases, and 90.9% for active TB cases.
Table 6 displays the bivariable and multivariable logistic
regression results for the following outcomes: (1) having a positive
QFNGIT result, (2) having a positive T-Spot.TB result, (3) having










Fever 37 (23.4) 29 (21.2) 8 (38.1)
Unexplained weight loss 6 (4.1) 4 (3.2) 2 (10.5)
Dyspnea 5 (3.2) 2 (1.5) 3 (14.3)
Abdominal pain 4 (2.6) 2 (1.5) 2 (9.5)
Abnormal lung exam 5 (3.2) 1 (0.8) 4 (19.1)
Enlarged lymph nodes 3 (1.9) 2 (1.5) 1 (4.8)
Abdominal ascites/distention 1 (0.7) 0 (0.0) 1 (4.8)
Meningismus 1 (0.7) 0 (0.0) 1 (4.8)
Chest radiograph findings NA
Normal 100 (63.7) 98 (72.1) 2 (9.5)
Hilar infiltrate(s) with lower lobe infiltrate(s) 4 (2.5) 2 (1.5) 2 (9.5)
Hilar infiltrate(s) with interstitial infiltrates 1 (0.6) 0 (0.0) 1 (4.8)
Hilar infiltrate(s) with lymph node disease 2 (1.3) 0 (0.0) 2 (9.5)
Interstitial infiltrate(s) with/
without lymph node disease
2 (1.3) 2 (1.5) 0 (0.0)
Infiltrate(s) with pleural effusion
Other infiltrate(s) 1 (0.6) 0 (0.0) 1 (4.8)
Lymph node disease only 39 (24.7) 28 (20.6) 11 (52.4)
Other 4 (2.5) 4 (2.9) 0 (0.0)
Missing/not done 4 (2.5) 2 (1.5) 2 (9.5)
TB microbiologic confirmation (N = 3) NA
AFB sputum or gastric lavage culture positive 2 (1.3) 0 (0.0) 2 (9.5)
M. TB PCR sputum or gastric lavage positive 0 (0.0) 0 (0.0) 0 (0.0)
AFB blood culture positive for M. TB 1 (0.6) 0 (0.0) 1 (4.8)
Child’s treatment course NA
No treatment 21 (13.6) 20 (15.0) 1 (4.8)
Active TB disease treatment 20 (13.0) 0 (0.0) 20 (95.2)
INH prophylaxis for latent TB 113 (73.4) 113 (85.0) 0 (0.0)
TST and IGRA Results, Baseline Month 0 Visit
Tuberculin skin test
$10 mm 102 (66.7) 88 (66.7) 14 (66.7) 1.00
$15 mm 59 (38.6) 48 (36.4) 11 (52.4) 0.16
QFNGIT result 0.04
Positive 51 (32.5) 40 (29.4) 11 (52.4)
Negative 106 (67.5) 96 (70.6) 10 (47.6)
Indeterminate 0 (0.0) 0 (0.0) 0 (0.0)
T-Spot.TB result 0.02
Positive 47 (29.9) 36 (26.5) 11 (52.4)
Negative 110 (70.1) 100 (73.5) 10 (47.6)
Equivocal/borderline 0 (0.0) 0 (0.0) 0 (0.0)
{Fisher’s exact.
NA: not applicable AFB: acid fast bacilli.
IGRA: Interferon gamma release assays QFNGIT: QuantiFERON Gold In-Tube.
*HIV testing was not offered because of lack of history of parental HIV infection and clinical signs/symptoms consistent with HIV infection.
doi:10.1371/journal.pone.0105003.t002
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TST$10 mm, and (5) having a TST$15 mm. In multivariable
analysis, having had exposure to a primary and secondary
caregiver in the household with TB (OR=4.07, 95% CI 1.38–
11.99 for primary caregiver, OR=3.95, 95% CI 1.25–12.52 for
secondary caregiver vs. relative or other contact in the household)
was significantly associated with having a positive QFNGIT result.
In multivariate analysis, having a higher TB contact score
(OR=3.15, 95% CI 1.35–7.34) and having active TB
(OR=3.03, 95% CI 1.11–8.29 vs. TB-exposed) were associated
with having a positive T-Spot.TB result. Having active TB
(OR=3.65, 95% CI 1.12–11.94 vs. TB-exposed) was significantly
associated with having both a positive T-Spot.TB and a positive
QFNGIT result. Older age (OR=1.14, 95% CI 1.03–1.26) was
associated with having a positive TST$10 mm, while older age
(OR=1.13, 95% CI 1.03–1.25) and having a primary caregiver in
the household with TB (OR=3.59, 95% CI 1.34–9.59) were
associated with having a positive TST$15 mm. Other variables
such as HIV status and weight-for-age Z-score were not
significantly associated with any of the IGRA and TST outcomes.
Discussion
In this first study directly comparing two IGRAs to TST in 158
children with recent exposure to an adult index case with active
TB in Thailand, we found that QFNGIT and T-Spot.TB
performed well without any indeterminate or equivocal/border-
line results. Past studies have shown that the proportion of children
with indeterminate results for IGRAs varied widely from 0–40%,
with higher proportions reported in children who were younger in
age, were malnourished, or had immunodeficiency or other acute
infections. [19–23] About two-thirds of our overall cohort had a
TST$10 mm induration and 38.6% had a TST$15 mm
induration, with no significant difference by TB infection status.
We observed that in the overall cohort and separately for TB-
exposed and active TB cases, QFNGIT and T-Spot.TB positivity
(32.5% and 29.9%, respectively) was lower than TST at both cut-
off thresholds. This finding is similar to a study among South
African school children with household TB contact that observed
33.2% of the children having a positive QFNGIT compared with
42.5% having a positive TST. Our test positivity rates differ from
other studies. In a study evaluating QFNGIT and TST among
children in Papua New Guinea, [15] QFNGIT was more likely to
be positive than TST in children with probable and possible TB
(34.2% vs. 24.9%). Compared to our study cohort, the Papua New
Guinea cohort was younger in age, had more children who were
nutritionally deficient as defined by weight-for-age Z-score, and
had more HIV-infected children; such differences might explain
the disparity in IGRA and TST positivity levels between the two
studies.
Our study found that both the IGRAs and TST at the two cut-
off thresholds performed well with increasing TB exposure
gradient. In addition, we did not detect any significant differences
between the performances of the tests with increasing TB
exposure, consistent with a meta-analysis by Mandalakas et al
comparing IGRAs with TST in TB-exposed children. [8] In a
Brazilian study among young children with recent TB exposure, a
linear, positive association was also noted between both QFNGIT
and TST and level of TB exposure. [24] Based on our finding of a
lack of superiority of the IGRAs over the TST with increasing TB
exposure, it appears that utilizing TST, as currently recommended
by the Thai national TB guidelines, would be a reasonable
alternative to the IGRAs, in diagnosing latent and active TB
infections in Thai children who match our study population (i.e.,
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compromise and who have previously received BCG vaccinations).
Importantly, the TST is widely accessible and affordable
compared to IGRAs, which also require operational capacity
(e.g., laboratory infrastructure), and may be more appropriate for
Thailand and other resource-limited settings.
Our study noted that both QFNGIT and T-Spot.TB positivity
was higher in children with active TB compared with TB-exposed
(55.0% vs. 29.2% for QFNGIT and 55.0% vs. 26.3% for T-
Spot.TB). No statistically significant difference in TST positivity at
the two cut-off thresholds, however, was seen between active and
TB-exposed cases. Compared with TB-exposed children, children
with active TB were 4.2 to 5.8 times more likely to have a positive
QFNGIT result, to have a positive T-Spot TB result, and to have
both positive QFNGIT and T-Spot TB results. Prior studies have
documented higher sensitivity of IGRAs compared with TST in
children with active TB. [11,15] However, in a United Kingdom
study in 209 children, the sensitivity of TST was 83% for culture-
confirmed, active TB, comparable to 80% for QFNGIT and
higher than 58% for T-Spot.TB [25].
In our study, we detected variable levels of agreement between
QFNGIT, T-Spot.TB, and TST at the two cut-off thresholds,
which is consistent with other studies that noted discrepancies
between IGRA and TST results among children in both low and
high TB incidence settings. [3,12,13,23,26] Levels of agreement
between QFNGIT and TST and between T-Spot.TB and TST
were low for our overall cohort, with kappa ranging from 0.32–
0.58 and 0.27–0.54, respectively, although higher levels of
agreement were seen with the 15 mm threshold compared with
10 mm and with active TB compared with TB-exposed cases.
Similar to a previous study, [22] many of the discordant results
were due to a QFNGIT2/TST+ or T-Spot.TB2/TST+,
particularly with the TST cut-off of 10 mm. This high rate of
false positive TST result may be attributable to high background
prevalence of BCG vaccination in our study population (as well as
in the general Thai pediatric population). The prevalence of
nontuberculous mycobacteria, which can affect the false positivity
rate of TST, is unknown in Thai children. Agreement between
QFNGIT and T-Spot.TB ranged from 0.71 to 0.81, comparable
to previous reports of agreement between the two IGRAs in
children. [25–27] We found that among TB-exposed children who
had a TST$10 mm, 41.4% had a positive QFNGIT result and
36.8% had a positive T-Spot.TB result. If IGRAs, rather than
TST with a cut-off of 10 mm, are used to guide who in the healthy
Thai pediatric population to start INH prophylaxis for latent TB,
it would reduce the number of children considered for preventive
treatment by approximately 60%, thereby potentially limiting the
number of children who may experience adverse medication-
related side effects.
Our study finding that children with active TB were more likely
than TB-exposed children to have been exposed to a secondary
caregiver in the household with TB and less likely have been
exposed to a primary caregiver or relative or other contact in the
Figure 1. The regression lines of the natural logs of the odds ratios (y-axis) for TST$10 mm, TST$15 mm, QFNGIT, and T-Spot. TB
for each TB exposure gradient category (x-axis), with TB contact score of 8–10 as the reference group.
doi:10.1371/journal.pone.0105003.g001
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household with TB compared with TB-exposed children may
appear counterintuitive. It is possible that the active TB children
were exposed to TB from secondary caregivers such as grandpar-
ents or household helpers, who might spend more time with the
children during the day (but not overnight), rather than from
primary caregivers such as parents. It is also possible that primary
caregivers with active TB might also be more likely to have
initiated anti-tuberculosis drugs and have decreased infectivity
than secondary caregivers with active TB. Designation of primary
and secondary caregiver might not have been consistent across all
participants. It is important to note that although we found a
difference with type of caregiver, there was no significant
difference in type of exposure, duration of average contact per
day, and duration of contact in the last 12 months to the index TB
case between active and TB-exposed children. In our multivar-
iable analysis, children who had exposure to a primary and
secondary caregiver in the household with TB were 3.5 to 4.3
times more likely, respectively, to have a positive QFNGIT result,
while those with a higher mean TB contact score were 3.15 times
more likely to have a positive T-Spot.TB. In addition, children
who had exposure to a primary caregiver in the household with
TB were 3.59 times more likely to have a TST$15 mm, but not
TST$10 mm. Our results are consistent with studies that showed
a strong correlation between positivity of IGRAs (as well as TST at
three different cut-off thresholds) and a high TB exposure
gradient. [8,28–30] Older age was found to be associated with
having a positive TST at both threshold levels, but not with a
positive QFNGIT or T-Spot.TB. Nutritional status, as measured
by weight-for-age Z-score, and HIV status were not associated
with a positive IGRA or TST, with the latter finding most likely
due to the small sample of children in our study with HIV
infection. Our findings differed from previous reports of IGRA
and TST results being affected by age, HIV status, and nutritional
status [31–33].
Our study has several limitations. Our study’s direct comparison
of IGRAs to TST involved comparing the performances of the
tests for increasing TB exposure gradient. As in other studies, our
analysis was complicated by the lack of gold standard in
diagnosing TB. [11,34] In addition, our small sample of active
TB cases (20 children) and high burden of childhood TB in
Thailand limited any sensitivity and specificity analyses using
active TB as a surrogate reference due to bias that could be arise
from these conditions. Our study only enrolled 3 HIV-infected
children, precluding a direct comparison of the IGRAs and TST
by HIV status. In addition, most of the children in our study who
were otherwise healthy, had no history of maternal positive HIV
serostatus, and had no HIV-related signs and symptoms were
presumed to be HIV-negative and did not receive HIV testing,
which might have resulted in misclassification bias. Strengths of
our study include the incorporation of both IGRAs (QFNGIT and
T-Spot.TB) to compare to TST at two different cut-off thresholds,
our use of extensive clinical, diagnostic, and microbiologic
parameters in determining or excluding active TB infection status,
overall excellent performance of the IGRAs with no indeterminate
or equivocal/borderline results, and very low rate of incomplete
IGRA testing by study participants (only 1 child did not complete
the IGRAs at the baseline visit).
Conclusions
In summary, both QFNGIT and T-Spot.TB performed well in
our generally healthy Thai pediatric study population with recent
exposure to adults with active pulmonary TB, with no indetermi-
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significant differences between the performances of the IGRAs
and TST at the two cut-offs with increasing TB exposure. Using
TST, as is currently recommended in the Thai national TB
guidelines, may be more ideal than IGRAs in diagnosing latent
and active TB in healthy Thai children given the lack of difference
in test performance between the diagnostic tests noted in our study
and given cost constraints (TST is considerably less expensive than
IGRAs) and logistics, with TST not requiring any laboratory
infrastructure. However, TST does have other operational
considerations, such as inter-reader variability and the need for
two separate visits for TST implant and reading, that the IGRAs
do not have that may make using the IGRAs in TB diagnosis
appealing.
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